Dialogues In Cardiovascular Medicine - Vol 21 .No. 4 .2016 .

3y ago
52 Views
2 Downloads
267.05 KB
12 Pages
Last View : 13d ago
Last Download : 3m ago
Upload by : Evelyn Loftin
Transcription

Dialogues in Cardiovascular Medicine - Vol 21 . No. 4 . 2016Coronary Artery Disease ImagingSummaries of Ten Seminal PapersInês Z. Cabrita, PhD1; Francisca P. Figueiras, PhD1; Fausto J. Pinto, MD, PhD21CETERA- Academic Consulting Research Organization - Association for Research and Developmentof the Faculty of Medicine (AIDFM) - Lisbon - PORTUGAL2 University Hospital Santa Maria - Department of Cardiology - Lisbon Academic Medical CentreCCUL - Lisbon - PORTUGAL (e-mail: faustopinto@medicina.ulisboa.pt)Dialogues Cardiovasc Med. 2016;21:293-30316Multimodality cardiovascularmolecular imaging, part IILow-dose CT coronary angiography with a novelIntraCycle motion-correction algorithm M. Nahrendorf and others.Circ Cardiovasc Imaging. 2009D. Andreini and others.Eur Heart J Cardiovasc Imaging. 201527Appropriateness criteria for cardiovascularimaging use in clinical practice: a positionstatement of the ESC/EACVI taskforcePrognostic value of coronary artery calcium scoringin addition to single-photon emission computedtomographic myocardial perfusion M. Garbi and others.Eur Heart J Cardiovasc Imaging. 2014E. M. Engbers and others.Circ Cardiovasc Imaging. 201638Outcomes of anatomical versus functional testingfor coronary artery diseaseWorkstation-based calculation ofCTA-based FFR for intermediate stenosisP. S. Douglas and others. N Engl J Med. 2015M. Kruk and others. JACC Cardiovasc Imaging. 201649Cardiovascular imaging practice in Europe:a report from the European Association ofCardiovascular ImagingEchocardiographic and fluoroscopic fusionimaging for procedural guidance: an overview andearly clinical experienceP. Lancellotti and others. Eur Heart J. 2015J. J. Thaden and others. J Am Soc Echocardiogr. 2016510Echocardiographic chamber quantificationin the era of multimodality imaging: bewareof unintended consequencesDiagnostic performance of the 3D bull’s eyedisplay of SPECT and coronary CTA fusionT. Nakahara and others.JACC Cardiovasc Imaging. 2016H. Feigenbaum. J Am Soc Echocardiogr. 2015Selection of seminal papers by Fausto J. Pinto, MD, PhDUniversity Hospital Santa Maria - Department of Cardiology Lisbon Academic Medical Centre - CCUL - Lisbon - PortugalCopyright 2016, AICH - Servier Research Group. All rights reservedHighlights of the years by Sherri Smith, PhDPublications office293www.dialogues-cvm.org

Dialogues in Cardiovascular Medicine - Vol 21 . No. 4 . 2016Summaries of Ten Seminal Papers - Cabrita and othersMultimodality cardiovascular molecular imaging, part IIM. Nahrendorf, D. E. Sosnovik, B. A. French, F. K. Swirski, F. Bengel, M. M. Sadeghi,J. R. Lindner, J. C. Wu, D. L. Kraitchman, Z. A. Fayad, et alCirc Cardiovasc Imaging. 2009;2:56-70Molecular imaging has the potential toimpact cardiovascular medicine in severalways, including risk assessment, earlydisease detection, development of personalized and targeted therapeutic regimens,and monitoring of therapeutic efficacy and outcome. Inaddition to these direct implications, molecular imagingwill affect clinical care indirectly by facilitating a more rapiddevelopment of novel pharmaceutics and improving thebasic understanding of cardiovascular pathophysiology.tion of the promise of cardiovascular molecular imagingwill thus require an ongoing and concerted collaborationbetween industry and both the basic science and imagingcommunities.“Smart” amplification strategies, comparative head-to-headanalysis of markers, improved reporter performance, andimproved hardware will enable the detection of minusculeor trace amounts of novel targets. These noninvasive andtargeted approaches will need to be tested for their prognostic value, cost effectiveness, and potential long-termtoxicity to translate these technological advances intoimproved patient care.Nahrendorf et al summarized the available targeted imaging probes and the specific future applications of molecularimaging for the identification and evaluation of criticalpathophysiological processes of the cardiovascular system.Novel imaging strategies for the evaluation of inflammation,thrombosis, apoptosis, necrosis, vascular remodeling, andangiogenesis were also included in the review. Nahrendorfet al also examined the role of targeted imaging for somecardiovascular diseases, such as atherosclerosis, ischemicinjury, postinfarction remodeling, and heart failure, andthe emerging fields of regenerative, genetic, and cellbased therapies.Particular emphasis is placed on multimodal imaging, asthese hybrid techniques promise to advance the field bycombining approaches with complementary strengths andoffsetting limitations. The routine application of molecularimaging in the management of patients with cardiovasculardisease is likely very close to being achieved. Molecularimaging should develop further with appropriate education of the cardiovascular community and the increasedavailability of various hybrid-imaging systems (ie, singlephoton emission computed tomography [SPECT]/computedtomography [CT], positron emission tomography [PET]-CT,PET-magnetic resonance imaging [MRI]) that will facilitatequantification of molecular imaging agents. A number ofchallenges, however, stand in the way of realizing thesepromises. Current imaging systems have not been optimized for cardiac applications due to the inadequate correction for cardiac and respiratory motion and a lack ofquantitative software for targeted agents. The full realiza-2009The longest-lasting total solar eclipse of the21st century occurs; the search for exoplanetsbegins with the launch of the Kepler spaceobservatory; and army ant specialistCarl Rettenmeyer dies at age 78294

Dialogues in Cardiovascular Medicine - Vol 21 . No. 4 . 2016Summaries of Ten Seminal Papers - Cabrita and othersAppropriateness criteria for cardiovascular imaging use in clinicalpractice: a position statement of the ESC/EACVI taskforceM. Garbi, G. Habib, S. Plein, D. Neglia, A. Kitsiou, E. Donal, F. Pinto, J. Bax, S. Achenbach,B. A. Popescu, et alEur Heart J Cardiovasc Imaging. 2014;15:477-482Interest from the scientific community is growing regarding the appropriate use of cardiovascular imaging techniques for diagnosis and decision makingin Europe. A dedicated taskforce has been appointedby the European Society of Cardiology (ESC) andthe European Association of Cardiovascular Imaging (EACVI)to develop appropriateness criteria for cardiovascular imaging use in clinical practice in Europe. Cardiovascularimaging is characterized by continuously evolving technology developments in all modalities. Therefore, assistancewith the decision-making process regarding both the choiceof imaging modality in a certain clinical scenario and thefuture development of availability at local, national, andEuropean levels becomes crucial.and Associations). Additionally, web-based tools and applications will be developed to assist with the clinical decision-making process and the selection of an appropriateimaging test for a particular indication.The appropriateness criteria will be patient-centered, facilitating the best use of cardiovascular imaging resourcesfor an individual who needs a test, while encouraging thebest use of material resources for the entire society, structured development of resources, efficient financial expenditure, and homogenization of care across Europe.The appropriateness criteria involve the evidence, guideline-based criteria, and best practice–based criteria forthe appropriate use of cardiovascular imaging modalitiesin clinical practice, which are meant to assist in the decision-making process. These appropriateness criteria will bedeveloped to ensure the best use of diagnostic cardiovascular imaging resources for a given individual, the rationaluse of cardiovascular imaging resources for all individualsin need of diagnosis, the most efficient use of availablefunds for society, and the judicious implementation ofevolving technology and evidence in clinical practice.The determination of appropriateness criteria, updated atregular 3-year intervals, will start with the appointment ofa panel of reviewers consisting of experts in each cardiovascular imaging modality and a voting panel. The panelwill make a selection of clinical scenarios; review the evidence, guidelines, position papers, etc; define indications;and assign an appropriateness score. For more informationon the development process, please see Figure 1 fromthe paper by Garbi et al.2014Eyesight has been restored in six patientsusing a new gene therapy technique;the tsetse fly genome sequencing project iscomplete after a 10-year multimillion dollar effort;and the length of a day for an exoplanetis measured for the first timeThe appropriateness criteria, statement papers, educational material, supporting clinical implementation, and allrelated documents will be made available online and distributed actively to different entities (eg, European Commission, the European National Societies, Working Groups,295

Dialogues in Cardiovascular Medicine - Vol 21 . No. 4 . 2016Summaries of Ten Seminal Papers - Cabrita and othersOutcomes of anatomical versus functional testing forcoronary artery diseaseP. S. Douglas, U. Hoffmann, M. R. Patel, D. B. Mark, H. R. Al-Khalidi, B. Cavanaugh,J. Cole, R. J. Dolor, C. B. Fordyce, M. Huang, et al; PROMISE InvestigatorsN Engl J Med. 2015;372:1291-1300Patients who have symptoms suggestive of coronary artery disease are often evaluated with theuse of diagnostic testing, although limited dataare available from randomized trials to guidecare. The coronary computed tomography angiography (CCTA) technique is one possible tool that mayreduce unnecessary invasive testing and improve patientoutcomes. However, the impact of data from noninvasive vsinvasive testing on the management of the disease andclinical outcomes is unknown. The PROMISE trial (PROspective Multicenter Imaging Study for Evaluation of chestpain) was designed to compare health-related outcomesbetween CCTA and functional testing in patients presentingwith symptoms of coronary artery disease that requiredfurther evaluation.functional testing group had no exposure, so the overallexposure was higher in the CCTA group (mean, 12.0 mSvvs 10.1 mSv; P 0.001).In conclusion, in symptomatic patients with suspectedcoronary artery disease who required noninvasive testing,an initial strategy of CCTA was not associated with betterclinical outcomes than functional testing over a medianfollow-up of 2 years.Douglas et al randomly assigned 10 003 symptomatic patients to a strategy of initial anatomical testing with theuse of either CCTA or functional testing (exercise electrocardiography, nuclear stress testing, or stress echocardiography). The composite primary end point was death, myocardial infarction, hospitalization for unstable angina, ormajor procedural complications. Secondary end points included radiation exposure and invasive cardiac catheterization that did not show obstructive coronary artery disease.The mean age of the patients was 60.8 8.3 years, 52.7%were women, and 87.7% had chest pain or dyspnea onexertion. The mean pretest likelihood of obstructive coronary artery disease was 53.3% 21.4%. Over a median follow-up period of 25 months, a primary end point eventoccurred in 164 of 4996 patients in the CCTA group (3.3%)and in 151 of 5007 (3.0%) in the functional testing group(adjusted hazard ratio, 1.04; 95% confidence interval, 0.83to 1.29; P 0.75). CCTA was associated with fewer catheterizations showing no obstructive coronary artery diseasethan functional testing (3.4% vs 4.3%; P 0.02), althoughmore patients in the CCTA group underwent catheterizationwithin 90 days after randomization (12.2% vs 8.1%). Themedian cumulative radiation exposure per patient was lower in the CCTA group than in the functional testing group(10.0 mSv vs 11.3 mSv), but 32.6% of the patients in the2015Biodegradable nanoparticles are used to killbrain cancer cells in animals;two lost cities in the Honduras jungle arediscovered; and an almost completely intactskeleton of a terror bird is found in Argentina296

Dialogues in Cardiovascular Medicine - Vol 21 . No. 4 . 2016Summaries of Ten Seminal Papers - Cabrita and othersCardiovascular imaging practice in Europe: a report from theEuropean Association of Cardiovascular ImagingP. Lancellotti, E. Płońska-Gościniak, M. Garbi, C. Bucciarelli-Ducci, B. Cosyns, N. Cardim,M. Galderisi, T. Edvardsen, D. Neglia, S. Plein, et alEur Heart J. 2015;16:697-702Epidemiology changes in cardiovascular diseaseand an aging population are expected to resultin an increased need for cardiovascular imaging(CVI). However, reliable statistics on the use ofCVI in Europe are lacking. The European Association of Cardiovascular Imaging (EACI) and the EuropeanSociety of Cardiology (ESC) Taskforce on CVI establishedthe status of CVI use across Europe. In 2013, a surveywith relevant information regarding CVI was sent to everynational imaging/echocardiography society and workinggroup. The survey was designed to assess existing education,training, certification and national accreditation programs,health care organizations, and reimbursement systems.Finally, the access to CVI examinations in the publichealth care system was marked by a long waiting periodin some countries.The current mapping of the practice of CVI techniquesacross Europe represents the first comprehensive projectof the ESC/EACVI Taskforce on CVI. The report symbolizesa preliminary step for further data collection and networking with national imaging societies and working groups.In the future, direct comparisons among the different ESCcountries should help standardize health care resourcesby promoting knowledge of their status and by bringingthis information to the attention of all public authorities.It is the hope that such data collection will contribute toimproved quality of care through a better use of resources(avoid unnecessary procedures and expenses) and a consequent reduction in the waiting time, thus increasing theavailability of CVI.The percentage of countries with a national certificationin CVI for cardiologists was different between imagingmodalities. Transthoracic and transesophageal echocardiography were commonly certified techniques, and aboutone-third of the countries had a certification program forthe other imaging modalities. The majority of nationalsocieties recommended the Imaging Taskforce of the EACI(EACVI) certification, but one-fifth of the societies hadtheir national certification system. Irrespective of the CVImodality, a national accreditation for centers/laboratorieswas not required for practice in most countries.Overall, there were diverse country-specific regulations forperforming CVI and a widespread lack of national certification/accreditation. However, the majority of countriesrecommended the EACVI certification and one-fifth of thecountries applied it as a national certification. Cardiologistscommonly performed echocardiography, but not computedtomography (CT), cardiovascular magnetic resonance imaging (CMR), or nuclear imaging. However, in most countries, medical imaging performance requires a specialistlicense (eg, cardiologist, radiologist, and a nuclear imagingspecialist). Unexpectedly, a predefined period of trainingin CVI during specialization was absent in one-third of thecountries. In addition, only a few countries offered officialnational certification guidelines to perform CVI examinations. Interestingly, the adherence to ESC/EACVI guidelinesin CVI was reported in a high number of European countries.2015The Japanese L0 Series maglev becomesthe first train to operate at a speed of 600 km/hour;NASA’s MESSENGER spacecraft concludesits 4-year orbital mission over Mercury;and the opah is confirmed as the firstwarm-blooded fish297

Dialogues in Cardiovascular Medicine - Vol 21 . No. 4 . 2016Summaries of Ten Seminal Papers - Cabrita and othersEchocardiographic chamber quantification in the era ofmultimodality imaging: beware of unintended consequencesH. FeigenbaumJ Am Soc Echocardiogr. 2015;28:847-850The primary purpose of the recently publishedupgrade to the guideline document for echocardiographic chamber quantification is to setstandard measurements, labels, and orientations to improve the communication andstandardization among all echocardiography laboratoriesboth in the United States and in Europe. Another aim ofupgrading the document was to integrate echocardiographicchamber quantification with other cardiovascular imagingmodality categories, with a notorious effort to recognizeechocardiography as part of the noninvasive cardiovascularimaging modalities. In this paper, Feigenbaum clearlyemphasizes that as with all changes or ‘‘advances,’’ thereare likely to be unexpected or unintended consequences,which has been the case for this modality.Care must be taken with the concept of integrated and‘‘consensus’’ multimodality imaging applications in theclinical setting.An early effort to improve the communication and coherence between echocardiography and nuclear cardiologywas to change echocardiography’s standard 16-segmentwall motion scoring system by adding a 17th segment atthe apex. Echocardiography representatives agreed to makethe change so that the scoring would be compatible withthe nuclear apical perfusion and multiple-gated acquisition scan for apical motion. However, it was later decidedthat due to recording specifications in echocardiographywhen using the 17-segment model to assess wall motionor regional strain, the 17th segment (the apical cap) shouldnot be included.Another effort was made to obtain standard echocardiographic segmentation labels and orientation so that theywould be similar to those used in nuclear perfusion. Unfortunately, this was not possible; for example, it was notpossible to standardize the labels for the right ventricleand the papillary muscle. Importantly, the back wall of theleft ventricle, which had been labeled ‘‘posterior,’’ is nowbeing labeled ‘‘inferior lateral’’ to make it compatible withnuclear cardiology. This change has caused some comprehensible controversy. Besides the desire to set standardmeasurements, labels, and orientation, there are likely tobe significant differences between echocardiography andcardiac computed tomography and magnetic resonance.2015Lokiarchaeota, a transitional form betweenArchaea and Eurkaryotes, is discovered;the US Fish and Wildlife Service declares thatthe eastern cougar is extinct; andthe first artificial ribosome is created298

Dialogues in Cardiovascular Medicine - Vol 21 . No. 4 . 2016Summaries of Ten Seminal Papers - Cabrita and othersLow-dose CT coronary angiography with a novel IntraCyclemotion-correction algorithm in patients with high heart rate orheart rate variabilityD. Andreini, G. Pontone, S. Mushtaq, E. Bertella, E. Conte, C. Segurini, A. Baggiano,A. L. Bartorelli, A. Annoni, A. Formenti, et alEur Heart J Cardiovasc Imaging. 2015;16:1093-1100While coronary computed tomography angiography (CCTA) has achieved good diagnostic performance, motion artifacts dueto a high heart rate or high heart ratevariability significantly affect the imagequality of CCTA. As a result, a motion-correction algorithm has been developed. In this study by Andreini et al,the impact of this algorithm when used in conjunctionwith low-dose prospective ECG-triggering CCTA on motionartifacts, image quality, and coronary assessability wasevaluated. Only one previous study assessed the diagnosticperformance of the motion-correction algorithm in conjunction with retrospective ECG-triggering CCTA in a smallpatient population referred for transcatheter aortic valveimplantation. A secondary aim of the study was to evaluate the diagnostic accuracy of CCTA performed with themotion-correction algorithm and standard reconstructionin comparison with invasive coronary angiography—thegold-standard imaging technique.variability, and high mean maximum heart rate duringscanning, CCTA with motion-correction recon

Dialogues in Cardiovascular Medicine - Vol 21 .No. 4 .2016 Summaries of Ten Seminal Papers - Cabrita and others pidemiology changes in cardiovascular disease and an aging population are expected to result in an increased need for cardiovascular imaging (CVI). However, reliable statistics on the use of CVI in Europe are lacking. The European .

Related Documents:

Menschen Pagina 20 Schritte international Neu Pagina 22 Motive Pagina 24 Akademie Deutsch Pagina 25 Starten wir! Pagina 26 Themen aktuell Pagina 28 em neu Pagina 29 Sicher! Pagina 30 Vol A1 1 Vol A1 Vol 1 Vol 1 2 Vol unico Vol 1 Volume 1 Volume 1 Vol 1 Vol 1 1 Vol A1 2 Vol 2 Vol 1 2 Vol A2 1 Vol A2 Vol 3 Vol

Akenson, Donald Harman Vol 8: 10 Alan, Radous, at Agincourt Vol 12: 1 Albert, King Vol 7: 45, 47 Albert, Prince Vol 12: 17; Vol 14: 1 Alden, John Vol 5: 34; Vol 9: 18 Alexander III Vol 13: 24 Aleyn, John, at Agincourt Vol 12: 1 Allen, Pat Vol 10: 44 Alling Vol 4: 26 Amore, Shirley Vol 12: 3 Anderson, Robert Vol 10: 46 Anderson, Virginia DeJohn .

The DRI Responsive Dialogues Toolkit outlines activities and steps needed to commission, design, plan and run Responsive Dialogues, and develop the ideas and solutions into policies and strategies that address AMR. Responsive Dialogues involve a series of at least

Cardiovascular System Cardiovascular system is sometimes called blood-vascular or simply referred to as the circulatory system. The cardiovascular system consists of the heart, which is a muscular pumping device, and a closed system of channels 1 F Kappel, “A MATHEMATICAL CARDIOVASCULAR MODEL WITH PULSATILE AND NON-PULSATILE

Introduction About IntelliSpace Cardiovascular 10 4522 170 26061 IntelliSpace Cardiovascular 2.3 Instructions for Use Philips Healthcare 1 Introduction 1.1 About IntelliSpace Cardiovascular IntelliSpace Cardiovascular is

cardiovascular disease cardiovascular associates of mesa pc alphonse ambrosia cardiovascular disease cardiovascular associates of mesa pc . cardiovascular disease phoenix heart pllc g reshmaal gomes-cumaranatunge . ironwood physicians pc joanne schlesinger hematology and o

equine medicine b. Food animal or large animal medicine c. Exotic animal medicine d. Marine animal medicine (mammal and fish) e. Poultry medicine f. Wildlife medicine and aquaculture medicine 2. Discuss with your counselor the roles a veterinarian plays in the following: a. Public health medicine and zoonotic disease surveillance and control b .

Object-oriented programming (OOP) The simplest Python class Class and object namespaces Attribute shadowing Me, myself, and I – using the self variable Initializing an instance OOP is about code reuse Inheritance and composition Accessing a base class Multiple inheritance Method resolution order Class and static methods Static methods Class methods Private methods and name .